Understanding New COVID Variants and Their Symptoms
As the COVID-19 pandemic continues into its third year, new variants of the SARS-CoV-2 virus continue to emerge. Some new variants, like Omicron, have caused major surges in cases due to their increased transmissibility or ability to evade immunity from prior infection and vaccines.
While the core symptoms of COVID remain similar across variants, some differences have been noted. Understanding the latest data on symptoms can help individuals make informed decisions about seeking care and testing if they experience potential COVID symptoms.
Most Common Symptoms of COVID-19
According to the CDC, people with COVID-19 have reported a wide variety of symptoms. The most common symptoms are:
- Fever or chills
- Cough
- Shortness of breath or difficulty breathing
- Fatigue
- Muscle or body aches
- Headache
- New loss of taste or smell
- Sore throat
- Congestion or runny nose
- Nausea or vomiting
- Diarrhea
Symptoms of New Variants Like Omicron
Emerging data indicates that new variants like Omicron may cause different symptoms compared to the original ancestral SARS-CoV-2 virus.
Several studies have suggested that Omicron infections present with symptoms that are more similar to cold or flu compared to earlier variants. Some of the more common symptoms of Omicron include:
- Cough
- Fatigue
- Congestion and runny nose
- Sore throat
- Headache
- Sneezing
- Muscle pains and fever seem less common
However, COVID infections caused by Omicron should not be ruled out on the basis of symptoms alone, as some people still present with typical COVID symptoms like loss of smell and taste.
Why Symptoms May Vary Between Variants
Researchers theorize there are a few reasons why Omicron and other variants may cause slightly different symptoms compared to original ancestral SARS-CoV-2:
- Mutations in the spike protein that change viral affinity for ACE2 receptors in the nose vs. lungs
- Ability of the variant to evade prior immunity leading to altered clinical picture
- Differences in populations impacted, with new variants spreading rapidly in young, vaccinated individuals so far.
Therefore, changes in symptom prevalence likely stem from a complex interplay between viral changes, population immunity, and demographic factors.
Monitoring for Severe Symptoms
While the symptoms caused by new variants may skew more mild on average, experts urge individuals to continue monitoring for symptoms of severe COVID requiring prompt medical care. These include:
- Difficulty breathing or shortness of breath
- Persistent chest pain or pressure
- New confusion
- Inability to wake or stay awake
- Pale, gray, or blue-colored skin, lips, or nail beds
If you or a loved one experiences these more dangerous symptoms of COVID, you should seek medical attention immediately.
How Long Symptoms Last with New Variants
Limited data is available currently on the duration of symptoms caused by Omicron, BA.2, or other new COVID variants. However, researchers expect:
- Symptoms may not last as long, on average, compared to prior variants
- Average symptom duration could be around 3 days for Omicron
- Those who are unvaccinated will likely experience longer lasting symptoms
Follow your physician's recommendations regarding isolation and precautions if you develop potential COVID-19 symptoms.
Tailoring Health Measures Based on Symptoms and Severity
Understanding the patient's symptom experience can help guide health system capacity planning and clinical care recommendations moving forward.
For example, variants associated with less severe outcomes may require:
- Less reliance on emergency departments/hospitals for case surges
- Outpatient antivirals vs. monoclonal antibodies or inpatient therapies
- Shorter isolation periods with appropriate precautions
On the other hand, variants that cause more severe disease will continue to warrant assertive public health measures to drive down overall case rates and reduce strain on healthcare systems.
The Importance of Testing
Due to shifting symptoms between variants, experts emphasize the continued need for widespread testing access and awareness campaigns surrounding evolving symptoms.
PCR nasal swab testing detecting active viral RNA remains the gold standard for diagnosing COVID-19 infection.
Newer rapid antigen tests are another important diagnostic tool between variants, although they may be slightly less sensitive compared to molecular PCR tests depending on the exact variant and test used.
Adapting Patient Messaging
Experts advise clinical settings and public health communicators to adapt patient messaging as new data emerges on variant symptoms.
Clear, up-to-date symptom checklists and targeted testing outreach should be emphasized in messaging across print materials, websites, social channels, and broadcast media.
Supporting At-Risk Communities
Public health agencies must remain vigilant regarding symptoms and outbreaks within vulnerable communities including seniors, the immunocompromised, individuals with multiple comorbidities, and those facing health equity barriers.
Targeted vaccination/antiviral campaigns, accessible testing, and culturally aligned symptom/severity education should be priorities in an adaptable pandemic response model.
The Importance of Shared Knowledge
While COVID-19 continues to present new challenges with emerging variants, up-to-date information on viral mutations, disease severity, and symptoms will help societies respond nimbly.
Experts urge individuals and public health decision makers alike to keep an open mind, stay informed through reputable sources, and remain responsive in this ever-changing pandemic landscape.
With collaborative real-world data platforms, transparent information sharing between public agencies and scientists, and pragmatic responses guided by compassion, nations around the globe can overcome COVID-19 in time.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a healthcare professional before starting any new treatment regimen.
Add Comment